Filing Details

Accession Number:
0000104207-14-000042
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-06 19:03:16
Reporting Period:
2014-06-04
Filing Date:
2014-06-06
Accepted Time:
2014-06-06 18:03:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
104207 Walgreen Co WAG Retail-Drug Stores And Proprietary Stores (5912) 361924025
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188858 A Mark Wagner 108 Wilmot Road
Deerfield IL 60015
President, Ops & Community Mgt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Walgreen Co. Common Stock Acquisiton 2014-06-04 4,603 $44.86 171,021 No 4 M Direct
Walgreen Co. Common Stock Disposition 2014-06-04 4,603 $75.00 166,418 No 4 S Direct
Walgreen Co. Common Stock Acquisiton 2014-06-04 21,497 $46.33 187,915 No 4 M Direct
Walgreen Co. Common Stock Disposition 2014-06-04 21,497 $75.00 166,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-04 4,603 $0.00 4,603 $44.86
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-04 21,497 $0.00 21,497 $46.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-03-01 2016-03-01 No 4 M Direct
0 2008-09-01 2015-09-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Walgreen Co. Common Stock 587 Indirect By spouse
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.01, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.
  3. Includes shares underlying restricted stock units issued in lieu of dividends (through May 21, 2014) on outstanding restricted stock units.